The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

Jul. 31, 2018
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Guochun Gong, Pleasantville, NY (US);

Charleen Hunt, Dumont, NJ (US);

Susannah Brydges, Putnam Valley, NY (US);

Suzanne Hartford, Putnam Valley, NY (US);

David Frendewey, New York, NY (US);

Brian Zambrowicz, Sleepy Hollow, NY (US);

Andrew J. Murphy, Croton-on-Hudson, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/90 (2006.01); C12N 15/861 (2006.01); C12N 15/877 (2010.01); A01K 67/027 (2006.01); C12N 9/38 (2006.01);
U.S. Cl.
CPC ...
C12N 15/907 (2013.01); A01K 67/0275 (2013.01); C12N 9/2471 (2013.01); C12N 15/861 (2013.01); C12N 15/8775 (2013.01); A01K 2217/07 (2013.01); A01K 2217/206 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0393 (2013.01); C12N 2310/20 (2017.05); C12N 2320/11 (2013.01); C12Y 302/01023 (2013.01);
Abstract

Methods and compositions are provided for assessing CRISPR/Cas-mediated non-homologous end joining (NHEJ) activity and/or CRISPR/Cas-induced recombination of a target genomic locus with an exogenous donor nucleic acid in vivo or ex vivo. The methods and compositions employ non-human animals comprising a CRISPR reporter such as a genomically integrated CRISPR reporter for detecting and measuring targeted excision of a sequence between two CRISPR/Cas nuclease cleavage sites or disruption of a sequence near a CRISPR/Cas nuclease cleavage site and/or measuring CRISPR/Cas-induced recombination of the CRISPR reporter with an exogenous donor nucleic acid to convert the coding sequence for a first reporter protein to the coding sequence for a different second reporter protein. Methods and compositions are also provided for making and using these non-human animals.


Find Patent Forward Citations

Loading…